Everolimus tedavisine bağlı interstisyel pnömoni

Everolimus tedavisine bağlı interstisyel pnömoni

Altmış yedi yaşında kadın hasta bir aydır halsizlik, nefes darlığı ve öksürük yakınması ile başvurdu. Hasta 2007 yılında sağ memede invaziv duktal karsinom nedeniyle cerrahi ve radyoterapi tedavisi gördüğünü ve dört ay önce de akciğerde multipl metastatik lezyonların saptanması üzerine everolimus te...

Full description

Bibliographic Details
Main Authors:	Nilüfer Aykaç Kongar, Ali Vefa Öztürk, Tolga Aktaş, Kerem Okutur, Metin Barlan
Format:	Article
Language:	English
Published:	Cukurova University 2016-12-01
Series:	Cukurova Medical Journal
Subjects:	everolimus interstitial pneumonitis bal medical history
Online Access:	https://dergipark.org.tr/tr/download/article-file/220851

Similar Items

Pneumocystis jirovecii pneumonia following everolimus treatment of metastatic breast cancer
by: Kelvin Teck-Hong Kuik, et al.
Published: (2014-10-01)

Sirolimus-induced interstitial lung disease and resolution after conversion to everolimus
by: Ahmed M. Alkhunaizi, et al.
Published: (2020-01-01)

The Impact of Everolimus and Radiation Therapy on Pulmonary Fibrosis
by: Mehmet Fuat Eren, et al.
Published: (2020-07-01)

Asphericity of Somatostatin Receptor Expression in Neuroendocrine Tumors: An Innovative Predictor of Outcome in Everolimus Treatment?
by: Christoph Wetz, et al.
Published: (2020-09-01)

Drug-related pneumonitis with radiographic hypersensitivity pneumonitis pattern: Three case series
by: Yukihiro Nakamura, et al.
Published: (2021-01-01)

Efficiency of late conversion from mycophenolate mofetil to everolimus in kidney graft recipients with posttransplant malignancy
by: I. G. Kim, et al.
Published: (2018-01-01)

Everolimus as a single agent in refractory or relapsed Hodgkin's lymphoma: the Brazilian Named Patient Program Experience
by: Talita Máira Bueno da Silveira da Rocha, et al.

Symptomatic improvement using everolimus in infants with cardiac rhabdomyoma
by: Bhargavi Dhulipudi, et al.
Published: (2019-01-01)

Successful maternal and fetal outcomes in a kidney transplant patient under everolimus throughout pregnancy complicated by pyelonephritis and preeclampsia
by: Amina Ousti, MD, et al.
Published: (2022-11-01)

The Role of Everolimus in Renal Cell Carcinoma
by: Malek Meskawi, et al.
Published: (2015-12-01)

Everolimus induced pulmonary thromboembolism after kidney transplantation; a case report
by: Fereshteh Saddadi, et al.
Published: (2022-01-01)

Effect and Complications of Everolimus Use for Giant Cardiac Rhabdomyomas with Neonatal Tuberous Sclerosis
by: Yuka Shibata, et al.
Published: (2019-07-01)

Analysis of early use of everolimus with low-dose calcineurin inhibitors in kidney transplant recipient
by: I. G. Kim, et al.
Published: (2019-10-01)

Use of Everolimus to treat cardiac rhabdomyomas and incessant arrhythmias in a newborn: Benefits and complications
by: Eyal Sagiv, et al.
Published: (2022-01-01)

Everolimus in combination with octreotide LAR in thymic atypical carcinoid
by: Tadashi Sakane, et al.
Published: (2023-05-01)

Everolimus Reduces the Size of Tuberous Sclerosis Complex-Related Huge Renal Angiomyolipomas Exceeding 20 cm in the Longest Diameter
by: Naoya Toriu, et al.
Published: (2018-05-01)

Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters
by: Maria Ingenerf, et al.
Published: (2022-10-01)

Everolimus in the Treatment of Neuroendocrine Tumors: Lights and Shadows
by: Bianca Medici, et al.
Published: (2025-02-01)

Experience of a Single Center in Treating Multiple Manifestations of Tuberous Sclerosis Complex with Everolimus
by: Hyunji Ahn, et al.
Published: (2019-12-01)

Recommendations for the use of everolimus in de novo kidney transplantation: False beliefs, myths and realities
by: Julio Pascual, et al.
Published: (2017-05-01)

EVEROLIMUS FOR KAPOSI'S SARCOMA TREATMENT AFTER KIDNEY TRANSPLANTATION
by: I. V. Alexandrov, et al.
Published: (2015-05-01)

Interactions between antifungals and everolimus against Cryptococcus neoformans
by: Pin Liang, et al.
Published: (2023-03-01)

Anti-tumour activity of everolimus and sunitinib in neuroendocrine neoplasms
by: Kosmas Daskalakis, et al.
Published: (2019-05-01)

A phase 1 evaluation of the safety and tolerability of niraparib in combination with everolimus in advanced ovarian and breast cancers
by: David Starks, et al.
Published: (2023-09-01)

The Synergistic Effect of Tacrolimus (FK506) or Everolimus and Azoles Against Scedosporium and Lomentospora Species In Vivo and In Vitro
by: Zikuo Wang, et al.
Published: (2022-04-01)

Investigation of the effects of mTOR inhibitors rapamycin and everolimus in combination with carboplatin on canine malignant melanoma cells
by: Sarah Bernard, et al.
Published: (2021-12-01)

Cardiac rhabdomyomas: clinical progression, efficacy and safety of everolimus treatment
by: Saygın Yıldırım, et al.
Published: (2023-06-01)

PHARMACOECONOMIC ANALYSIS OF EVEROLIMUS IMMUNOSUPRESSIVE THERAPY AFTER RENAL TRANSPLANTATION
by: M. V. Avxentyeva, et al.
Published: (2015-06-01)

In Vitro Interactions of Antifungal Agents and Everolimus Against Aspergillus Species
by: Huiping Jiang, et al.
Published: (2022-07-01)

Everolimus Treatment for Chronic Lung Allograft Dysfunction in Lung Transplantation
by: David Iturbe-Fernández, et al.
Published: (2024-05-01)

Everolimus Nanoformulation in Biological Nanoparticles Increases Drug Responsiveness in Resistant and Low-Responsive Breast Cancer Cell Lines
by: Arianna Bonizzi, et al.
Published: (2019-08-01)

Use of everolimus as an alternative to calcineurin inhibitors in renal allograft recipients: A single South Indian center's experience
by: Manns Manohar John, et al.
Published: (2019-01-01)

Immunosuppressive Effects and Potent Anti-tumor Efficacy of mTOR Inhibitor Everolimus in Breast Tumor-bearing Mice
by: Davoud Rostamzadeh, et al.
Published: (2022-06-01)

Telomerase Inhibition by Everolimus Suppresses Smooth Muscle Cell Proliferation and Neointima Formation Through Epigenetic Gene Silencing
by: Jun Aono, MD, PhD, et al.
Published: (2016-01-01)

Inhibitory effects of everolimus in combination with paclitaxel on adriamycin-resistant breast cancer cell line MDA-MB-231
by: Tinghua Xu, et al.
Published: (2020-11-01)

The experience of use of everolimus in patients having undergone to orthotopic liver transplantation
by: V. E. Syutkin, et al.
Published: (2018-08-01)

Everolimus induced organizing pneumonia in a patient with tuberous sclerosis complex
by: Julio Lanfranco, et al.
Published: (2021-01-01)

A systematic review and meta-analysis comparing everolimus and calcineurin inhibitors (CNIs) to mycophenolate and CNIs in kidney transplant patients
by: Larraine Vergara-Rejante, et al.
Published: (2023-03-01)

Efficacy and safety of everolimus treatment in a hemodialysis patient with metastatic atypical bronchial carcinoid: case report and literature review
by: M. P. Brizzi, et al.
Published: (2018-03-01)

Analysis of the synergistic antifungal activity of everolimus and antifungal drugs against dematiaceous fungi
by: Lulu An, et al.
Published: (2023-02-01)